TrialIntensive care medicine2025

Heterogenous treatment effect of neuromuscular blocking agents for moderate-to-severe ARDS: a post hoc Markov model re-analysis of the ACURASYS trial.

Michael Brunini et al.PubMed ↗Publisher ↗

No numbers read from the abstract.